Royal Bank of Canada’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $215K | Buy |
10,573
+1,486
| +16% | +$30.2K | ﹤0.01% | 4765 |
|
|
2025
Q1 | $182K | Buy |
9,087
+191
| +2% | +$3.83K | ﹤0.01% | 4421 |
|
|
2024
Q4 | $237K | Sell |
8,896
-2,355
| -21% | -$62.7K | ﹤0.01% | 4221 |
|
|
2024
Q3 | $321K | Buy |
11,251
+4,530
| +67% | +$129K | ﹤0.01% | 4022 |
|
|
2024
Q2 | $147K | Buy |
6,721
+3,569
| +113% | +$78.1K | ﹤0.01% | 4607 |
|
|
2024
Q1 | $70K | Sell |
3,152
-6,687
| -68% | -$149K | ﹤0.01% | 4933 |
|
|
2023
Q4 | $212K | Buy |
9,839
+5,380
| +121% | +$116K | ﹤0.01% | 4541 |
|
|
2023
Q3 | $76K | Buy |
4,459
+1,579
| +55% | +$26.9K | ﹤0.01% | 5068 |
|
|
2023
Q2 | $39K | Buy |
2,880
+830
| +40% | +$11.2K | ﹤0.01% | 5442 |
|
|
2023
Q1 | $47K | Sell |
2,050
-2,177
| -52% | -$49.9K | ﹤0.01% | 5270 |
|
|
2022
Q4 | $99K | Buy |
4,227
+1,120
| +36% | +$26.2K | ﹤0.01% | 4994 |
|
|
2022
Q3 | $81K | Sell |
3,107
-2,085
| -40% | -$54.4K | ﹤0.01% | 4968 |
|
|
2022
Q2 | $114K | Buy |
5,192
+3,530
| +212% | +$77.5K | ﹤0.01% | 4779 |
|
|
2022
Q1 | $75K | Sell |
1,662
-3,342
| -67% | -$151K | ﹤0.01% | 5351 |
|
|
2021
Q4 | $214K | Buy |
5,004
+1,977
| +65% | +$84.5K | ﹤0.01% | 4759 |
|
|
2021
Q3 | $202K | Buy |
3,027
+1,252
| +71% | +$83.5K | ﹤0.01% | 4662 |
|
|
2021
Q2 | $130K | Buy |
1,775
+235
| +15% | +$17.2K | ﹤0.01% | 4952 |
|
|
2021
Q1 | $106K | Sell |
1,540
-1,136
| -42% | -$78.2K | ﹤0.01% | 4935 |
|
|
2020
Q4 | $179K | Sell |
2,676
-1,799
| -40% | -$120K | ﹤0.01% | 4408 |
|
|
2020
Q3 | $230K | Buy |
4,475
+4,018
| +879% | +$207K | ﹤0.01% | 3988 |
|
|
2020
Q2 | $17K | Buy |
457
+264
| +137% | +$9.82K | ﹤0.01% | 5171 |
|
|
2020
Q1 | $6K | Sell |
193
-81
| -30% | -$2.52K | ﹤0.01% | 5468 |
|
|
2019
Q4 | $9K | Buy |
+274
| New | +$9K | ﹤0.01% | 5571 |
|